b'condition. This study in primary and secondaryDr. ThrowerWeve all been dealing with the progressive MS did show slowing of progressionCOVID-19 pandemic for more than two years of disability. Stay tuned.now. Hopefully, we are through the worst of COVID infection not linkedit. The MS community had many questions to increased MS risk about COVID-19. Are vaccines safe and recommended? How does my MS therapy ResearchersinIranconductedanaffect my risk of COVID-19 or my response to observational study from July 2020 to Julyvaccinations? Does COVID-19 infection put 2021 in the Isfahan MS clinic. They comparedme at risk for a relapse or progression of the trends of probable disability progressiondisability? In our MS Center, the majority of and relapses before and after probable/people who had COVID-19 infections recovered denitive COVID-19 diagnosis in a cohort ofcompletely. We had to pay special attention to people with RRMS. Fifty-three people withthose on B-cell therapies (i.e. Ocrevus, Rituxan, relapsing MS were identied with denitiveand Kesimpta), as there can be a higher risk COVID-19 for analysis. Clinical activity of RRMSfor hospitalization, ICU stays, and death with was increased in the people with relapsing MS COVID-19 infections in that group. In our who were hospitalized, because of COVID-19experience,thiswasamuchbiggerissue suggestingaconnectionwithseverityofwith the Delta variant of COVID-19 than with COVID-19,butitcouldnotbeconrmed.Omicron. We also know that people on B-cell Overall, the study did not show an increasetherapies may be less likely to get a good in PDP but there were signicant limitationsantibody response to the COVID-19 vaccination. thattheauthorsacknowledgedincludingThis small study gives us some good news because it shows us that the COVID-19 infection small sample size and a selection bias. Awas not associated with an increased risk for larger sample size is needed to draw anyMS relapse or progression of disability. I know denitiveconclusions.Thendingswerewe all look forward to putting COVID-19 in published in BMC Neurology.the rear-view mirror. Survey and an Opportunity to Win a $100 Amazon Gift Card from MS Focus At the Multiple Sclerosis Foundation, we tailor our efforts to the needs of the MS community. Our services, educational programs, and publications are all designed with you in mind. But in order to do that successfully, we need your input.Will you please spend 2-5 minutes of your time taking a brief survey about your MS symptoms? This will help us learn how to better serve you. As a thank you for your time, you can choose to be entered into a random drawing to win one of ve Amazon gift cards. Our rst place winner will receive a $100 Amazon gift card. Two second place winners will receive $50 Amazon gift cards. Two third place winners will receive $25 Amazon gift cards.Take the survey now at: msfocus.us/symptoms2259 msfocusmagazine.org'